Recipharm buys Abbott plant to tap Spanish market
Recipharm buys contract manufacturing plant in Spain to gain foothold in one of Europe’s "most interesting" markets.
Archives for October 3, 2010
Taxol precursors produced in engineered E coli
Cost-effective, large-scale production of oncology drug Taxol (paclitaxel) intermediates could eventually be achieved using engineered Escherichia coli.
Sanofi launches hostile Genzyme bid; Pfizer close on Uplyso Brazil deal
French drugmaker Sanofi Aventis has tabled an $18.5m, $69 per share, hostile takeover bid for Genzyme after failing to secure an amicable acquisition.
BioClinica shareholder calls for managment resignations
BioClinica shareholder Nicusa Capital is calling for the resignation of CEO Mark Weinstein, CFO Ted Kaminer and Chairman David Nowiki, after describing the firm’s corporate strategy as “defective.”
PPD expands Russian presence with Novosibirsk office
US CRO PPD has opened a new office in Novosibirsk, Russia to provide clinical monitoring services for its Phase II-IV trial business.
Quintiles, HKPI and Ramco form Egyptian company, HKPI-JV
Quintiles has established a joint venture with Health Kare Pharma International (HKPI) and Ramco Import and Export, focused on providing pharmaceutical contract sales and promotional services in Egypt.
Regulatory expert insight: electronic submission
Adoption of electronic submission by regulators around the world is good news for drugmakers’ efforts to access emerging markets says industry expert Kate Wilber.